NCT00234546View on ClinicalTrials.gov

Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2007

Conditions
Muscle SpasticityCerebrovascular Accident
Interventions
BIOLOGICAL

Botulinum toxin type A

1 injection, 500 U at day 0. The study will last for 6 months in each patient.

DRUG

Placebo

1 injection at day 0. The study will last for 6 months in each patient.

Trial Locations (5)

10700

Siriraj Hospital, Bangkok

59100

University Hospital of Malaya Medical Centre, Kuala Lumpur

569766

TTSH Rehabilitation Centre, Singapore

Unknown

Prince of Wales Hospital, Shatin

3001 MAB

University of Santo Tomas, Manila

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT00234546 - Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity | Biotech Hunter | Biotech Hunter